BIOMARIN PHARMA revenue breakdown overview

BIOMARIN PHARMA revenue for the last year amounted to 2.04 B CHF, the most of which — 2.04 B CHF — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 1.94 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought BIOMARIN PHARMA 649.40 M CHF, and the year before that — 632.78 M CHF.